Navigation Links
Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology
Date:12/1/2009

CAMBRIDGE, Mass., Dec. 1 /PRNewswire/ -- To address the emergence of the synthetic biology industry and to promote its potential, a group of individuals and companies announced the formation of the Synthetic Biology Industry Association (SynBIA) in Cambridge, Massachusetts last week. The goal of the association is to provide a forum for individuals and commercial interests to discuss the new industry, address its opportunities and its challenges, and advocate for its development. Founding members include representatives of febit, GENEART, Ginkgo BioWorks, Biosearch Technologies and Sutro Biopharma.

The association will serve as the trade association home for a diverse group of companies and individuals involved in synthetic biology development, including companies involved in gene synthesis, pharmaceutical development, energy development, and pollution control. The goal is to responsibly join the public discussion and promote development.

Among the more specific goals of SynBIA is an informed discussion about the risks and rewards of development. This includes participation in the discussion of dual use and in the current discussion regarding voluntary screening obligations (codes of conduct). Association members are active participants in meetings with the FBI, the National Academy of Sciences and the Association for the Advancement of Science relating to the developing synthetic biology field.

Founding Chairman JD Kittle noted, "The industry has strong potential to be a part of the solution to problems in the world's health, energy and environmental arenas. SynBIA plans to be a part of the discussion advocating for increased funding to enhance participation in these areas."

Founding Board member, Mark Waxman of Foley & Lardner, also pointed out that with the increasing visibility, IP portfolios, and transaction volume, there is a developing need for an association to address industry issues. Founding board member Frank Notka of GENEART complemented, "These industry issues have to be tackled with regard to the international character and the resulting challenges for transnational arrangements. SynBIA will through its international composition and orientation contribute to this scheme."

The SynBIA will have a collaborative relationship with the International Association of Synthetic Biology (IASB) and, through that relationship, seek to enhance international relationships developing in this field. The IASB is the international platform for synthetic biology as a field of activity. Cord F. Staehler, CEO and President of febit who is a founder and board member of both SynBIA and IASB stated, "We welcome this new addition, as it is important to have an international approach to this new and exciting industry."

For more information about SynBIA please visit www.synbia.org

For information about SynBIA please contact: jkittlejr@gmail.com

For information about IASB please contact: info@ia-sb.eu or visit www.ia-sb.eu


Contact:
Martina Schwarzkopf
Russo Partners
212-845-4292
martina.schwarzkopf@russopartnersllc.com

SOURCE Synthetic Biology Industry Association (SynBIA)


'/>"/>
SOURCE Synthetic Biology Industry Association (SynBIA)
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
2. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
3. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
4. Favrille CEO to Present at NewsMakers in the Biotech Industry Investment Conference
5. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
6. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
7. TorreyPines Therapeutics to Present at the NewsMakers in the Biotech Industry Conference
8. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference
9. Anesiva to Present at BioCenturys NewsMakers in the Biotech Industry Conference on September 6, 2007
10. BioCryst to Present at the BioCentury NewsMakers in the Biotech Industry Conference
11. Suntech to Attend Upcoming Investor Conferences and Industry Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , ... June 23, 2016 , ... In a new ... in Denmark detail how a patient who developed lymphedema after being treated for breast ... results could change the paradigm for dealing with this debilitating, frequent side effect of ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
Breaking Biology Technology:
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
Breaking Biology News(10 mins):